Target intelligence / Profile preview

Spindlin-1 (SPIN1)

Target
SPIN1
Molecular classification
Chromatin reader, Tudor domain-containing protein, Histone modification effector protein, Transcriptional co-activator
01

Overview

Spindlin-1 is a chromatin reader protein encoded by the SPIN1 gene in humans. It contains three Tudor-like domains that specifically recognize and bind to histone H3 trimethylated at lysine 4 (H3K4me3) and lysine 9 (H3K9me3), integrating into the regulation of chromatin structure and gene transcription[2][4][6]. Spindlin-1 acts as a transcriptional co-activator, promotes expression of rRNA genes, and is implicated in cell cycle control[1][2]. It is highly expressed in certain cancer cells, such as ovarian cancer, and has been identified as a putative oncogene[1][4]. The protein localizes mainly to the nucleolus and at rDNA loci, participating in selective transcriptional activation. Small molecule inhibitors have been developed to target its Tudor domains, representing a potential therapeutic strategy for cancer where SPIN1 is dysregulated[4].

Other names
Spindlin1SPIN1Spin1Meiotic spindle-binding proteinSpin/Ssty gene family protein
02

Mechanism of action

Inhibition of chromatin reader function by blocking Tudor domain-mediated recognition of methylated histone marks Modulation of gene transcription via disruption of chromatin effector complexes

03

Biological functions

Recognition of methylated histone marks (especially H3K4me3 and H3K9me3)Regulation of ribosomal RNA gene transcriptionModulation of chromatin structureTranscriptional co-activationCell cycle regulation
04

Disease associations

Cancer (notably ovarian cancer and squamous cell carcinoma)Potentially cancer-related inflammation/metastasis
05

Safety considerations

Potential on-target effects on cell proliferation or ribosome biogenesis, given role in rRNA transcription and the cell cycleUncharacterized risks in normal cell physiology due to the essential nature of chromatin regulation and cell division
06

Interacting drugs

Small molecule inhibitor: SPIN1 chemical probe (selective Tudor domain inhibitor)

1 more in the full profile.

Beyond the preview

Go deeper on Spindlin-1 (SPIN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spindlin-1 (SPIN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call